Literature DB >> 1499658

Excitatory effects of adenosine 5'-triphosphate on rat locus coeruleus neurones.

M Tschöpl1, L Harms, W Nörenberg, P Illes.   

Abstract

Pontine slices of the rat brain were used for extracellular recording of the frequency of spontaneous action potentials of locus coeruleus (LC) neurones. In the absence of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), alpha,beta-methyleneadenosine 5'-triphosphate (alpha,beta-meATP; 0.3-30 mumol/l) and 2-methylthio ATP (0.3-100 mumol/l), but not ATP (1-100 mumol/l) increased the firing rate. In the presence of DPCPX 0.1 mumol/l, all three purinoceptor agonists were active, the potency order being alpha,beta-meATP greater than 2-methylthio ATP = ATP. Preincubation of the slices with tetrodotoxin (TTX) 0.5 mumol/l decreased the spike discharge but did not alter the percent facilitatory effect of alpha,beta-meATP 30 mumol/l. There was no desensitization to alpha,beta-meATP 10 mumol/l on repeated or continuous application. Suramin 100 mumol/l selectively depressed the effect of alpha,beta-meATP 30 mumol/l without interfering with the effect of equiactive concentrations (10-100 mumol/l) of glutamic acid. The concentration-response curve of alpha,beta-meATP was shifted in a parallel manner to the right by suramin 10 mumol/l. While DPCPX 0.1 mumol/l facilitated firing, suramin 100 mumol/l did not change it. In conclusion, LC neurones may possess P2-purinoceptors of an unidentified type, which share some P2x characteristics.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499658     DOI: 10.1016/0014-2999(92)90234-u

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes.

Authors:  K Xiong; C Li; F F Weight
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  P2 receptor excitation of rodent hypoglossal motoneuron activity in vitro and in vivo: a molecular physiological analysis.

Authors:  G D Funk; R Kanjhan; C Walsh; J Lipski; A M Comer; M A Parkis; G D Housley
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

3.  Purinergic modulation of cardiovascular function in the rat locus coeruleus.

Authors:  Song T Yao; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve.

Authors:  D J Trezise; I Kennedy; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Cultured chick sympathetic neurons: ATP-induced noradrenaline release and its blockade by nicotinic receptor antagonists.

Authors:  C Allgaier; H Wellmann; A Schobert; G Kurz; I von Kügelgen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

6.  Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.

Authors:  J Pintor; M A Díaz-Rey; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

7.  Colocalization of ATP and nicotinic ACh receptors in the identified vagal preganglionic neurone of rat.

Authors:  J Nabekura; S Ueno; T Ogawa; N Akaike
Journal:  J Physiol       Date:  1995-12-01       Impact factor: 5.182

8.  Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

Authors:  J Gonçalves; G Queiroz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  P2X2 and P2Y1 immunofluorescence in rat neostriatal medium-spiny projection neurones and cholinergic interneurones is not linked to respective purinergic receptor function.

Authors:  Peter Scheibler; Mihail Pesic; Heike Franke; Robert Reinhardt; Kerstin Wirkner; Peter Illes; Wolfgang Nörenberg
Journal:  Br J Pharmacol       Date:  2004-09       Impact factor: 8.739

10.  Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.